Regulatory News
Sunday, July 17, 2016
Samsung Bioepis seeks Europe approval for its Humira copy
SEOUL, July 18 (Reuters) - Biosimilars maker Samsung
Bioepis, part of South Korea's top family-run conglomerate
Samsung Group, said on Monday it is seeking regulatory
approval in Europe to sell its...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment